EP 4240406 A1 20230913 - ASSESSMENT OF CANCERS FOR TREATMENT WITH A CD33/CD3 BISPECIFIC T CELL ENGAGER
Title (en)
ASSESSMENT OF CANCERS FOR TREATMENT WITH A CD33/CD3 BISPECIFIC T CELL ENGAGER
Title (de)
BEURTEILUNG VON KREBS ZUR BEHANDLUNG MIT EINEM CD33/CD3-BISPEZIFISCHEN T-ZELL-ENGAGER
Title (fr)
ÉVALUATION DE CANCERS POUR LE TRAITEMENT AVEC UN ANTICORPS BITE CD33/CD3
Publication
Application
Priority
- US 202063110011 P 20201105
- US 2021058254 W 20211105
Abstract (en)
[origin: WO2022099006A1] Methods for assessing potential for treatment of certain cancers with a bispecific T cell engager having two CD33 binding domains and two CD3 binding domains are described. The methods entail assessing clustering of CD33 on tumor cells, e.g., leukemic blast.
IPC 8 full level
A61K 39/00 (2006.01); A61P 35/02 (2006.01); C07K 16/28 (2006.01)
CPC (source: EP)
A61P 35/02 (2017.12); C07K 16/2803 (2013.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/626 (2013.01); C07K 2317/73 (2013.01); C07K 2317/75 (2013.01); C07K 2317/76 (2013.01)
Citation (search report)
See references of WO 2022099006A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
US 2021058254 W 20211105; EP 21816264 A 20211105